Showing results (1291-1300 of 6,769) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|September 6, 2015
Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United StatesElizabeth L Eby, Kate Van Brunt, Cynthia Brusko, et al.
Clinical Therapeutics|September 27, 2014
Meta-analysis to assess the efficacy and toxicity of docetaxel-based doublet compared with docetaxel alone for patients with advanced NSCLC who failed first-line treatmentYing Jin, Yan Sun, Xun Shi, et al.
Clinical Therapeutics|August 31, 2015
Cobicistat: Review of a Pharmacokinetic Enhancer for HIV InfectionElizabeth M Sherman, Marylee V Worley, Nathan R Unger, et al.
Clinical Therapeutics|September 2, 2015
Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care MedicationsStevie Rowe, David Siegel, Daniel K Benjamin, et al.
Clinical Therapeutics|January 17, 2015
Cervical cancer survivorship: long-term quality of life and social supportKrista S Pfaendler, Lari Wenzel, Mindy B Mechanic, et al.
Clinical Therapeutics|January 21, 2015
Simeprevir and sofosbuvir for treatment of chronic hepatitis C infectionLindsey M Childs-Kean, Elizabeth O Hand
Clinical Therapeutics|August 6, 2015
Patterns of Innovation in Alzheimer's Disease Drug Development: A Strategic Assessment Based on Technological MaturityJennifer M Beierlein, Laura M McNamee, Michael J Walsh, et al.
Clinical Therapeutics|August 6, 2015
Enzyme Replacement Therapies and Immunogenicity in Lysosomal Storage Diseases: Is There a Pattern?Paul Harmatz
Clinical Therapeutics|July 23, 2014
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritisKirandeep Kaur, Sonesh Kalra, Sandeep Kaushal
Clinical Therapeutics|July 30, 2014
Cost-minimization analysis of lanthanum carbonate versus sevelamer hydrochloride in US patients with end-stage renal diseaseMichael S Keith, Rosamund J Wilson, Peter Preston, et al.
Pageof 677